Immunodetection of Na,K-ATPase α3-isoform in renal and nerve tissues  by Arystarkhova, E.A. et al.
Volume 250, number 2, 545-548 FEB 07329 July 1989 
Immunodetection of Na,K-ATPase 3-isoform in renal and nerve 
tissues 
E.A. Arystarkhova, O.E. Lakhtina and N.N. Modyanov 
Shemyakin Institute of Bioorganic Chemistry, USSR Academy of Sciences, Moscow, USSR 
Received 27 April 1989 
At least three types of mRNA of the catalytic subunit of Na,K-ATPase namely ~t-,~t+- and ~t3-isoforms are identified 
in different issues. Only two of them ~t and ~t + have well known structural and catalytic properties. Here we present 
immunochemical data indicating that the ~t3 protein really exists in pig and human kidney, and human brain. Crude 
membrane fractions and purified membrane-bound Na,K-ATPases were immunoblotted with ~t3-specific antibodies 
raised against the synthetic peptide corresponding tothe unique sequence of this isoform. The mature ~t3-subunit is shown 
to include the sequence GDKKDDKSSPK followed by the initiating methionine residue. Nephron collecting tubules 
are proposed to specifically contain Na,K-ATPase ~t3-isoform. 
Catalytic subunit isoform; Antipeptide specific antibody; Western-blot analysis; ATPase, (Na + K)- 
1. INTRODUCTION 
The Na,K-activated a enosine triphosphatase of 
animal plasma membranes is a universal system for 
the active transport of monovalent cations. An en- 
zyme effects vector transmembrane transfer of 
Na + and K ÷ against their electrochemical potential 
gradients due to the energy of ATP hydrolysis. The 
enzyme molecule consists of two polypeptides, 
catalytic a-subunit and glycoprotein ~'of unknown 
function (for review see [1]). To date, the number 
of known genes for the Na,K-ATPase catalytic 
subunit [2] exceeds that of identified protein 
isoforms (only cr and a~+ subunits have been 
characterized bybiochemical methods [3]). A com- 
plete nucleotide sequence of the gene for the 
ot3-isoform of the catalytic subunit is established 
[4], the gene expression in various organs and 
tissues is studied (a,3 mRNA is detected in rat brain 
[5], stomach, lung, liver and fetal heart [6], human 
kidney [7]). All these underlay the search for a pro- 
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tein product of the a3 gene expression. This report 
presents immunobiochemical d ta indicating that 
the o~3-isoform of the catalytic subunit of Na,K- 
ATPase really exists in renal and nerve tissues. 
2. MATERIALS AND METHODS 
Kidney microsomes and Na,K-ATPase were pr0pared aS in 
[8]. Partial purification of Na,K-ATPase from huntan brain by 
extraction with SDS was performed as in [3] except hat the 
detergent/protein ratio was decreased to 0.3. 
Two peptides corresponding to the a3-subunit regions were 
synthesized following the solid-phase technique [9]. Peptide I
was coupled to Keyhole limpet hemocyanin (KLH) and bovia© 
serum albumin (BSA) using glutaraldehyde and peptide II, 
coupled to KLH with N-succinimidyl 3-(2-pyridyldithio)prr- 
pionate as described in [10]. 
Rabbits were immunized by two subcutaneous injections of 
peptide II (1 mg) or peptide conjugates (500/zg) with a 2 week 
interval. Antipeptide antibodies (aBSA-I, aKLH-I) were 
purified by affinity chromatography on Sepharose 4B with the 
immobilized peptide I. The thiol-Sepharose 413 coupled with 
peptide II, by specially adding an N-terminal cysteine residue, 
was used to purify antibodies a-II and aKLH-II. 
Antibody binding to the peptides (1-2/zg/ml) or Na,K- 
ATPase (5-10/,g/ml) was detected by an indirect solid-phase 
ELISA [9]. SDS-PAGE (4-15 ~0) and immunoblotting was car- 
ried out as in [9]. The blots were treated with biotinylated goat 
anti-rabbit IgG (1:1000) followed by incubation with strep- 
tavidin (1 : 1000) and horseradish-peroxidase (HRP)-conjugated 
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biotin (1:500). An alternative procedure included staining of 
the specific antigen-antibody complex by goat anti-rabbit IgG 
conjugated to HRP (1 : 1000). 
3. RESULTS AND DISCUSSION 
To elucidate the distribution of the protein pro- 
duct of Na,K-ATPase a3-isoform gene expression, 
the antibodies obtained to the unique segment of 
the protein structure proved to be a very useful 
tool. The comparison of the primary structures 
derived from the nucleotide sequences of o~ [11], 
+ [12] and ~3 [4] revealed the notable difference 
in two regions (fig. 1). Both the peptides are located 
in the regions of the molecule involved directly or 
indirectly in functioning of the protein. The first 
peptide adjoins the ATP-binding site, the second is 
in the N-terminal part of the molecule significant 
for cation transport [1]. Such disposition implies 
location of these regions on the molecule surface 
that is naturally essential for further epitope 
recognition with antibodies. 
Two synthetic peptides 10-11 amino acids in 
length were used as antigens to raise specific an- 
tibodies: (I) ETEDPNDNRY; (II) GDKKDDK- 
SSP. As the o~3-isoform RNA content is substan- 
tial in renal [7] and nerve tissues [6], the protein is 
assumed to enter the enzyme isolated from kidney 
as a minor component. The membrane-bound 
Na,K-ATPase from pig kidney outer medulla was 
subjected to ELISA with various dilutions of 
aKLH-I, aBSA-I and a-c~p999 [9]. (Only two 
amino acid substitutions Ile(ce)/Leu(a3) and 
Arg(ce)/Asn(~3) allowed supposition that the an- 
tibodies will recognize both enzyme isoforms 
equally well.) The same height of the upper plateau 
on titration curves demonstrates the identical an- 
tigen quantity in three binding processes. This can 
be explained by nonspecific interaction of aBSA-I 
antibodies and the Na,K-ATPase ce-subunit region 
(227-236) 
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There is no doubt about he exposure of this frag- 
ment in membrane-bound ATPase complex, and 
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Fig.1. Comparative s quence analysis of the Na,K-ATPase o~ 
[11], ce + [12] and o~3 [4] isoforms. The regions of nonhomology 
have been boxed. 
consequently, about its accessibility, since this 
region is obviously involved in acception of the 
enzyme-specific inhibitor, ouabain [13,14]. 
Hence a series of experiments on obtaining an- 
tibodies against synthetic peptide II was perform- 
ed, the peptide being supposed to include the 
N-terminal region of the ot3-subunit molecule. 
Since four Lys and three Asp residues enter the 
peptide, we specially added a cysteine residue to 
the N-terminus of peptide II for coupling. 
Simultaneous immunization was performed by two 
distinct antigens: the peptide conjugated to 
keyhole hemocyanin (KLH-II) and free peptide II.
Then polyclonal sera and affinity purified 
monospecific antibodies were used in Western-blot 
analysis to probe the presence and relative quan- 
tities of the corresponding a3 antigen. To avoid a 
possible pitfall of unequal recovery of Na,K- 
ATPase isozymes during membrane preparation, 
initial experiments were performed with the most 
inclusive possible particulate fractions from pig 
kidney medulla nd cortex as well as from human 
kidney and brain. No positive hybridization signal 
was observed when an anti-rabbit IgG conjugated 
to horseradish peroxidase was used to reveal 
specific complexes. The lack of detectable ce3 
subunit could indicate that the antigen is absent 
from the microsomes analyzed. Besides, the lack 
of a region corresponding to peptide II in the 
mature protein of the ce3-isoform could also be one 
of the reasons. However, it may be the result of a 
low level of re3 antigen (below detection level of the 
ELISA with secondary antibody-HRP conjugate). 
Use was made of the avidin-biotin system to 
amplify a possible positive signal. In this case 
(fig.2), only a polypeptide with molecular mass of 
100 kDa and its dimer were detected inmicrosomal 
fractions. Na,K-ATPase purified preparations 
used as antigens in immunoblotting provided the 
identical results (fig.3). The specificity of the reac- 
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Fig.2. Immunodetection f Na,K-ATPase oe3-isoform in kidney 
and brain. Western type immunoblots were performed on 
4-15% gel gradient containing the microsomes from human 
kidney (100/Lg) (lanes 1,5,7), human brain (250/~g) (lanes 
2,6,8), pig renal outer medulla (100~g) (lane 3) and cortex 
(100/~g) (lane 4). The blots were stained with (A) Coomassie 
G-250; (B) the antipeptide antiserum a-II diluted 100-fold; (C) 
the nonimmune serum (1 : 100). 
tion was proved by the lack of immunolabelling 
when electrotransferred proteins were incubated 
with sera absorbed with peptide II. In preparation, 
adsorption on thiol-Sepharose immobilized p p- 
tide was carried out. Titer decrease with respect o 
the peptide demonstrated serum depletion. No 
reactive band was seen on immunoblots when 
either this preparation or nonimmune IgG (figs 
2,3) were used. 
Positive hybridization signals detected in im- 
munoblotting after amplification give evidence 
that first, the c~3-isoform of the catalytic subunit 
of Na,K-ATPase is present as a minor component 
in mammalian kidney and brain (pig, human), 
with the content, evidently, being two orders lower 
of that of the tr-subunit. Second, the N-terminus 
of  the mature protein molecule includes peptide II 
or at least its part, whereupon this region is suffi- 
ciently conservative in the mammalian enzyme 
(rat, pig, human). 
The functional properties of the Na,K-ATPase 
containing the ce3 chain remain uncertain. One of 
them could deal with endogenous regulators. By 
studying Na,K-ATPase at the level of single well 
defined nephron segments, the differences in 
Na,K-ATPase sensitivity to and affinity for oua- 
Fig.3. Immunoblot staining of purified Na,K-ATPase from 
human kidney (lanes 1,6,8), human brain (lanes 2,5,7), pig 
kidney outer medulla (lane 4) and cortex (lane 3). The blots 
were treated with (A) Coomassie G-250; (B) the antipeptide 
antiserum a-lI (1:100); (C  the antiserum a-lI preliminary 
depleted with peptide II immobilized on thiol-Sepharose 
0:100). 
bain along the nephron were demonstrated [15]. 
The proximal tubule was found to have a low sen- 
sitivity to ouabain whereas the collecting tubule 
was about 30-fold more sensitive. So there would 
obviously be a need for more than one form of 
Na,K-ATPase in kidney. The ce3-isoform of the 
catalytic subunit can be such a protein, its sensitivi- 
ty to ouabain seems to be two orders of magnitude 
higher in comparison with Na,K-ATPase a- 
polypeptide [16]. Nephron collecting tubules are 
known to span medulla and cortex, so it is logical 
to speculate that they contain the oe3-isoform that 
may be the target for endogenous ouabain-like 
factors. 
A weaker signal observed when analysing the 
preparations i olated from human brain, certainly 
gives no evidence of less protein content in nerve 
tissues as compared with kidney. Probably, the 
fine analysis of brain segments and its tissues will 
reveal a precise localization of the a3-isoform. 
The quantity estimation of the a3-isoform 
distribution in various tissues is difficult in a way 
and can be caused by insufficient sensitivity of the 
methods applied, by possible partial protein loss in 
the course of fraction enrichment and elec- 
trophoretic transfer upon immunoblotting. This is 
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why the application of immunocytochemical 
methods seems more reasonable in this case. At 
present we are engaged in works on localization of 
the oe3-isoform by specific antibodies on sections 
and cell cultures of various animal tissues. 
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